1) Tsuji E, et al : Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer, 107 : 303-308, 2003
2) DeWys WD, et al : Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med, 69 : 491-497, 1980
3) Dudrick SJ, et al : Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery, 64 : 134-142, 1968
4) Deitch EA, et al : The gut as a portal of entry for bacteremia. Role of protein malnutrition. Ann Surg, 205 : 681-692, 1987
5) Tanaka H, et al : Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury. Gastroenterology, 114 : 714-723, 1998
6) Kakinuma S & Ohwada S : Gastric mucosal blood flow and gastric secretion following intravenous administration of 5-fluorouracil in anesthetized rats. Cancer Chemotherapy & Pharmacology, 39 : 357-360, 1997
7) Sartori S, et al : Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study. Cancer, 78 : 1477-1482, 1996
8) Siber GR, et al : Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma. Cancer Research, 40 : 3430-3436, 1980
9) Gil SM, et al : Bacterial translocation : the effect of supplements with dietary fiber in enteral diets in an experimental model of methotrexate-induced enterocolitis. Nutricion Hospitalaria (in Spanish), 9 : 375-384, 1994
10) Tisdale MJ : Cachexia in cancer patients. Nat Rev Cancer, 2 : 862-871, 2002
11) Dewys WD, et al : Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med, 69 : 491-497, 1980
12) Laviano A & Meguid MM : Nutritional issues in cancer management. Nutrition, 12 : 358-371, 1996
13) McGeer AJ, et al : Parenteral nutrition in cancer patients undergoing chemotherapy : a meta-analysis. Nutrition, 6 : 233-240, 1990
14) Fredrix EW, et al : Resting energy expenditure in patients with non-small cell lung cancer. Cancer, 68 : 1616-1621, 1991
15) Vardy JL, et al : Cytokine levels in patients with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function. J Clin Oncol, 25 : 9070, 2007
16) Cabal-Manzano R, et al : Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer, 84 : 1599-1601, 2001
17) Khan S & Tisdale MJ : Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor. Int J Cancer, 80 : 444-447. 1999
18) Todorov P, et al : Characterization of a cancer cachectic factor. Nature, 379 : 739, 1996
19) Tisdale MJ : The" cancer cachectic factor". Support Care Cancer, 11 : 73-78, 2003
20) Laviano A, et al : Therapy insight : Cancer anorexia-cachexia syndrome--when all you can eat is yourself. Nat Clin Pract Oncol, 2 : 158-165, 2005
21) Rofe AM, et al : Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res, 14 : 647-650, 1994
22) Ravasco P, et al : Cancer : disease and nutrition are key determinants of patients' quality of life. Support Care Cancer, 12 : 246-252, 2004
23) Walsh D, et al : Symptoms and prognosis in advanced cancer. Support Care Cancer, 10 : 385-388, 2002
24) Isenring EA, et al : Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer, 91 : 447-452, 2004
25) Jho D, et al : Omega-3 fatty acids : implications for the treatment of tumor-associated inflammation. Am Surg, 69 : 32-36, 2003
26) Tisdale MJ & Beck SA : Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid. Biochem Pharmacol, 41 : 103-107, 1991
27) Bruera E, et al : Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia : a double-blind, placebo-controlled study. Clin Oncol, 21 : 129-134, 2003
28) May PE, et al : Reversal of cancer-related wasting using oral supplementation with a combination of betahydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg, 183 : 471-479, 2002
29) Loprinzi CL, et al : Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol, 17 : 3299-3306, 1999
30) Jatoi A, et al : A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer, 68 : 234-239, 2010
31) Gordon JN, et al : Thalidomide in the treatment of cancer cachexia : a randomised placebo controlled trial. Gut, 54 : 540-545, 2005
32) Edelman MJ, et al : Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome. Cancer, 86 : 684-688, 1999
33) 奥山治美, 他 : 日薬理誌, 131 : 259-267, 2008
34) 「静脈経腸栄養ガイドライン 第3版」 (日本静脈経腸栄養学会/編), 照林社, 2013
35) Miyata H, et al : Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr, 31 : 330-336, 2012
36) 川守田龍, 他 : 頭頸部IMRT (Intensity Modulated Radiation Therapy) における経時的な頭頸部領域体積の変化と線量分布への影響. 日放腫会誌, 18 : 199-207, 2006
37) Beer KT, et al : Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer. Nutr Cancer, 52 : 29-34, 2005
38) Langmore S, et al : Does PEG use cause dysphagia in head and neck cancer patients? Dysphagia, 27 : 251-259, 2012
39) Aoyama T, et al : Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol, 20 : 2000-2006, 2013
40) Gabrielson DK, et al : Use of an Abridged Scored Patient-Generated Subjective Global Assessment (abPG-SGA) as a Nutritional Screening Tool for Cancer Patients in an Outpatient Setting. Nutrition and Cancer, 65 : 234-239, 2013